- Home
- BHLB vs ATRC Comparison
BHLB vs ATRC Comparison
Compare BHLB & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHLB
- ATRC
- Stock Information
- Founded
- BHLB 1846
- ATRC 2000
- Country
- BHLB United States
- ATRC United States
- Employees
- BHLB N/A
- ATRC N/A
- Industry
- BHLB Banks
- ATRC Medical/Dental Instruments
- Sector
- BHLB Finance
- ATRC Health Care
- Exchange
- BHLB Nasdaq
- ATRC Nasdaq
- Market Cap
- BHLB 1.3B
- ATRC 1.1B
- IPO Year
- BHLB 2000
- ATRC 2005
- Fundamental
- Price
- BHLB $29.84
- ATRC $31.43
- Analyst Decision
- BHLB Hold
- ATRC Strong Buy
- Analyst Count
- BHLB 5
- ATRC 9
- Target Price
- BHLB $30.80
- ATRC $41.78
- AVG Volume (30 Days)
- BHLB 354.0K
- ATRC 366.6K
- Earning Date
- BHLB 01-23-2025
- ATRC 10-29-2024
- Dividend Yield
- BHLB 2.47%
- ATRC N/A
- EPS Growth
- BHLB N/A
- ATRC N/A
- EPS
- BHLB 0.93
- ATRC N/A
- Revenue
- BHLB $344,859,000.00
- ATRC $447,573,000.00
- Revenue This Year
- BHLB N/A
- ATRC $17.75
- Revenue Next Year
- BHLB $3.43
- ATRC $13.44
- P/E Ratio
- BHLB $32.06
- ATRC N/A
- Revenue Growth
- BHLB N/A
- ATRC 17.56
- 52 Week Low
- BHLB $20.50
- ATRC $18.94
- 52 Week High
- BHLB $32.36
- ATRC $39.05
- Technical
- Relative Strength Index (RSI)
- BHLB 48.09
- ATRC 32.86
- Support Level
- BHLB $28.68
- ATRC $31.23
- Resistance Level
- BHLB $30.53
- ATRC $32.16
- Average True Range (ATR)
- BHLB 0.75
- ATRC 1.20
- MACD
- BHLB -0.22
- ATRC -0.63
- Stochastic Oscillator
- BHLB 43.92
- ATRC 3.78
About BHLB Berkshire Hills Bancorp Inc.
Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.